关注
Sneha Dhapare
Sneha Dhapare
Pharmacologist, FDA
在 fda.hhs.gov 的电子邮件经过验证
标题
引用次数
引用次数
年份
CFD guided optimization of nose-to-lung aerosol delivery in adults: effects of inhalation waveforms and synchronized aerosol delivery
R Dutta, B Spence, X Wei, S Dhapare, M Hindle, PW Longest
Pharmaceutical research 37 (10), 199, 2020
192020
Scientific and regulatory activities initiated by the US food and drug administration to foster approvals of generic dry powder inhalers: bioequivalence perspective
B Newman, A Babiskin, E Bielski, S Boc, S Dhapare, L Fang, K Feibus, ...
Advanced Drug Delivery Reviews 190, 114526, 2022
162022
Development of a high-flow nasal cannula and pharmaceutical aerosol combination device
BM Spence, W Longest, X Wei, S Dhapare, M Hindle
Journal of aerosol medicine and pulmonary drug delivery 32 (4), 224-241, 2019
152019
Excipient Enhanced Growth Aerosol Surfactant Replacement Therapy in an In Vivo Rat Lung Injury Model
FJ Kamga Gninzeko, MS Valentine, CK Tho, SR Chindal, S Boc, ...
Journal of Aerosol Medicine and Pulmonary Drug Delivery 33 (6), 314-322, 2020
132020
Sulfated dehydropolymer of caffeic acid: In vitro anti-lung cell death activity and in vivo intervention in emphysema induced by VEGF receptor blockade
TM Truong, H Li, S Dhapare, UR Desai, NF Voelkel, M Sakagami
Pulmonary pharmacology & therapeutics 45, 181-190, 2017
132017
Advancements in the design and development of dry powder inhalers and potential implications for generic development
AR Mohan, Q Wang, S Dhapare, E Bielski, A Kaviratna, L Han, S Boc, ...
Pharmaceutics 14 (11), 2495, 2022
92022
Scientific and regulatory activities initiated by the US Food and Drug Administration to foster approvals of generic dry powder inhalers: quality perspective
N El-Gendy, CM Bertha, M Abd El-Shafy, DK Gaglani, A Babiskin, ...
Advanced Drug Delivery Reviews 189, 114519, 2022
82022
Salvianolic acid B as an anti-emphysema agent I: in vitro stimulation of lung cell proliferation and migration, and protection against lung cell death, and in vivo lung STAT3 …
S Dhapare, M Sakagami
Pulmonary Pharmacology & Therapeutics 53, 107-115, 2018
82018
Effect of differential drying techniques on PLGA nanoparticles containing hydrophobic and hydrophilic anticancer agents
SS Dhapare, AK Dash
Therapeutic delivery 6 (1), 27-39, 2015
82015
Medication cost-savings and utilization of generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) drug products in the USA
Z Wang, SK Ahluwalia, B Newman, S Dhapare, L Zhao, MC Luke
Therapeutic Innovation & Regulatory Science 56 (2), 346-357, 2022
62022
Considerations for the Forced Expiratory Volume in 1 Second‐Based Comparative Clinical Endpoint Bioequivalence Studies for Orally Inhaled Drug Products
J Lee, K Feng, DS Conti, R Walenga, M Wientjes, H Wang, B Newman, ...
Clinical Pharmacology & Therapeutics 112 (5), 982-989, 2022
42022
Pharmacokinetic profile analyses for inhaled drugs in humans using the lung delivery and disposition model
A Raut, S Dhapare, J Venitz, M Sakagami
Biopharmaceutics & Drug Disposition 41 (1-2), 32-43, 2020
42020
Salvianolic acid B as an anti-emphysema agent II: In vivo reversal activities in two rat models of emphysema
S Dhapare, H Li, M Sakagami
Pulmonary Pharmacology & Therapeutics 53, 52-60, 2018
42018
Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays
E Amini, SM Berger, U Schilling, Y Jiao, MJ Chen, S Bachhav, ...
Molecular Pharmaceutics 20 (11), 5690-5700, 2023
12023
Multifunctional nanoparticles containing hydrophilic and hydrophobic drugs for anticancer drug delivery
S Dhapare
Creighton University, 2013
12013
In vitro evaluation of intersubject variability in pediatric intranasal drug delivery using nasal spray suspension products
AR Esmaeili, JV Wilkins, S Hosseini, A Alfaifi, M Hejazi, M Hindle, ...
Journal of Aerosol Science 179, 106387, 2024
2024
Combination devices, systems, and methods for humidification of the airways and high efficiency delivery of pharmaceutical aerosols
PW LONGEST, M Hindle, B Spence, S Dhapare, W Xiangyin
US Patent 11,534,569, 2022
2022
Effects of Realistic In Vitro Test Factors on the Aerosol Properties of Metered-Dose Inhalers (MDIs)
S Dhapare, A Mohan, B Newman, M Svensson, P Elfman, D Sandell, ...
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 35 (2), A6-A7, 2022
2022
Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective
ZL El-Gendy N, Bertha CM, Abd El-Shafy M, Gaglani DK, Babiskin A, Bielski E ...
Advanced Drug Delivery Reviews 189, 114519, 2022
2022
Systematic Evaluation of the Effect of Formulation Variables on In Vitro Performance of Mometasone Furoate Suspension-Metered Dose Inhalers
SS Bachhav, P Sheth, D Sandell, M Svensson, S Bhagwat, DS Conti, ...
The AAPS journal 24 (1), 9, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20